Word

IMMUNOCHARGING

Status

Dead

Status Code

606

Status Date

Monday, September 4, 2023

Serial Number

90326590

Mark Type

4000

Filing Date

Wednesday, November 18, 2020

Published for Opposition

Tuesday, June 8, 2021

Abandoned Date

Monday, September 4, 2023

Trademark Owner History

Celularity Inc. - Owner At Publication

Classifications

5 Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; surgical implants comprised of living tissue, namely, human amniotic membrane and human chorionic membrane intended for subsequent implantation; surgical implants comprised of living tissue, namely, human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological products for medical use in the nature of biological preparations, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for treating cancer or other disease-associated antigen; pharmaceutical preparations for wounds, namely, biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; written instructional materials distributed in connection with the aforesaid goods packaged with the goods; biological products for medical use, namely, biological preparations in the nature of placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for treatment of cancer or other disease-associated antigen

1 Bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research

42 Research, development and testing services for others in the fields of genomics, biotechnology and pharmaceuticals; stem cell research services; research, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; laboratory research services in the field of genomics, biotechnology and pharmaceuticals consisting of collection, testing, processing, preservation, storage and retrieval of bioengineered cells, human allograft tissue made from human umbilical cords and human placentas, human amniotic membrane and human chorionic membrane, human collagen and extracellular matrix compositions; providing technical writing and a website featuring information in the field of medical research relating to banking stem cells and cord blood banking; biological research, namely, biosourcing of clinically accessible, immune-tolerant human stem and progenitor and other postpartum placenta-derived cell populations and tissues for medical research; medical research to find methods to restore the structure and function of damaged or diseased tissues and organs, including wound care, reconstructive medicine, whole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line information, news and commentary in the field of medical research relating to the foregoing

IMMUNO CHARGING

Trademark Events

Sep 5, 2023

Abandonment Notice E-Mailed - No Use Statement Filed

Sep 4, 2023

Abandonment - No Use Statement Filed

Dec 29, 2022

Notice Of Approval Of Extension Request E-Mailed

Dec 27, 2022

Sou Extension 3 Granted

Dec 27, 2022

Sou Extension 3 Filed

Dec 27, 2022

Sou Teas Extension Received

Jul 7, 2022

Notice Of Approval Of Extension Request E-Mailed

Jul 5, 2022

Sou Extension 2 Granted

Jul 5, 2022

Sou Extension 2 Filed

Jul 5, 2022

Sou Teas Extension Received

Jan 5, 2022

Notice Of Approval Of Extension Request E-Mailed

Jan 3, 2022

Sou Extension 1 Granted

Jan 3, 2022

Sou Extension 1 Filed

Jan 3, 2022

Sou Teas Extension Received

Aug 3, 2021

Noa E-Mailed - Sou Required From Applicant

Jun 8, 2021

Official Gazette Publication Confirmation E-Mailed

Jun 8, 2021

Published For Opposition

May 19, 2021

Notification Of Notice Of Publication E-Mailed

May 3, 2021

Approved For Pub - Principal Register

May 3, 2021

Examiner's Amendment Entered

May 3, 2021

Notification Of Examiners Amendment E-Mailed

May 3, 2021

Examiners Amendment E-Mailed

May 3, 2021

Examiners Amendment -Written

Apr 30, 2021

Assigned To Examiner

Jan 21, 2021

New Application Office Supplied Data Entered

Nov 21, 2020

New Application Entered